Published in QJM on August 27, 2010
TNF biology, pathogenic mechanisms and emerging therapeutic strategies. Nat Rev Rheumatol (2015) 1.10
Demyelinating Disease following Anti-TNFa Treatment: A Causal or Coincidental Association? Report of Four Cases and Review of the Literature. Case Rep Neurol Med (2013) 1.00
Peripheral blood derived gene panels predict response to infliximab in rheumatoid arthritis and Crohn's disease. Genome Med (2013) 0.92
Modulating the Innate Immune Response to Influenza A Virus: Potential Therapeutic Use of Anti-Inflammatory Drugs. Front Immunol (2015) 0.90
Simultaneous targeting of TNF and Ang2 with a novel bispecific antibody enhances efficacy in an in vivo model of arthritis. MAbs (2012) 0.89
Tumor necrosis factor inhibitors - state of knowledge. Arch Med Sci (2014) 0.87
Off-label uses of anti-TNF therapy in three frequent disorders: Behçet's disease, sarcoidosis, and noninfectious uveitis. Mediators Inflamm (2013) 0.85
Management of cutaneous disorders related to inflammatory bowel disease. Ann Gastroenterol (2012) 0.84
Crohn's disease successfully treated with infliximab in a patient receiving hemodialysis: case report and review of the literature. Medicine (Baltimore) (2014) 0.80
Infliximab and Dexamethasone Attenuate the Ductular Reaction in Mice. Sci Rep (2016) 0.75
Novel Immunotherapies for Autoimmune Hepatitis. Front Pediatr (2017) 0.75
Acne inversa: difficulties in diagnostics and therapy. Postepy Dermatol Alergol (2015) 0.75
TNF--a antagonists and sarcoidosis. QJM (2011) 0.75
EULAR recommendations for the management of Behçet disease. Ann Rheum Dis (2008) 3.37
Effect of infliximab on sight-threatening panuveitis in Behçet's disease. Lancet (2001) 2.95
Oncogene-induced replication stress preferentially targets common fragile sites in preneoplastic lesions. A genome-wide study. Oncogene (2007) 1.85
Imatinib for the treatment of refractory, diffuse systemic sclerosis. Rheumatology (Oxford) (2008) 1.83
A pilot study of endothelial dysfunction and aortic stiffness after interleukin-6 receptor inhibition in rheumatoid arthritis. Atherosclerosis (2011) 1.78
Glutamate levels and activity of the T cell voltage-gated potassium Kv1.3 channel in patients with systemic lupus erythematosus. Arthritis Rheum (2008) 1.51
Small airways dysfunction in systemic sclerosis. A controlled study. Chest (1992) 1.39
Management of Behçet disease: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for the management of Behçet disease. Ann Rheum Dis (2008) 1.32
Retinal toxicity in long term hydroxychloroquine treatment. Ann Rheum Dis (1996) 1.27
Infliximab for recurrent, sight-threatening ocular inflammation in Adamantiades-Behçet disease. Ann Intern Med (2004) 1.13
B-cell kinase lyn deficiency in patients with systemic lupus erythematosus. J Investig Med (2001) 1.13
Hypersensitivity reactions to carboplatin administration are common but not always severe: a 10-year experience. Oncology (2001) 1.12
Defective antigen-presenting cell function in patients with systemic lupus erythematosus. Arthritis Rheum (1996) 0.94
Nocebo in fibromyalgia: meta-analysis of placebo-controlled clinical trials and implications for practice. Eur J Neurol (2011) 0.94
Acute transverse myelitis and antiphospholipid antibodies in lupus. No evidence for anticoagulation. Eur J Neurol (2010) 0.92
Irinotecan as salvage chemotherapy for advanced small bowel adenocarcinoma: a series of three patients. J Chemother (2003) 0.91
Myocardial performance and aortic elasticity are impaired in patients with ankylosing spondylitis. Scand J Rheumatol (2009) 0.90
The association of systemic lupus erythematosus and myasthenia gravis. Postgrad Med J (1994) 0.89
Tuberculosis and granuloma formation in patients receiving anti-TNF therapy. Int J Tuberc Lung Dis (2006) 0.86
Serum concentrations of soluble intercellular adhesion molecule-1 and progress towards disease in patients infected with HIV. J Infect (1994) 0.86
Psoriasiform lesions appearing in three patients with rheumatoid arthritis during therapeutic administration of abatacept, a selective inhibitor of T-cell costimulation. J Eur Acad Dermatol Venereol (2011) 0.86
Cutaneous vasculitis associated with mixed cryoglobulinemia in adult Still's disease. Clin Exp Rheumatol (2003) 0.86
Aortic stiffness in systemic sclerosis is increased independently of the extent of skin involvement. Rheumatology (Oxford) (2004) 0.85
Quinolinic acid in patients with systemic lupus erythematosus and neuropsychiatric manifestations. J Rheumatol (1996) 0.84
Soluble interleukin-2 receptor is a thyroid hormone-dependent early-response marker in the treatment of thyrotoxicosis. Clin Diagn Lab Immunol (1997) 0.84
Tuberculosis of the sacroiliac joint. Eur Spine J (1997) 0.82
Lung scintigraphy with nonspecific human immunoglobulin G ((99m)Tc-HIG) in the evaluation of pulmonary involvement in connective tissue diseases: correlation with pulmonary function tests (PFTs) and high-resolution computed tomography (HRCT). Eur J Nucl Med Mol Imaging (2007) 0.82
Lack of response to corticosteroids and pulse cyclophosphamide therapy in Cogan's syndrome. Clin Rheumatol (1994) 0.81
Prevalence of diabetes mellitus and obesity in the general adult population of Greece: a door-to-door epidemiological study. Diabet Med (2009) 0.81
Elevated soluble CD8 antigen and soluble interleukin-2 receptors in the sera of patients with juvenile rheumatoid arthritis. Clin Immunol Immunopathol (1993) 0.81
Immune cell signaling aberrations in human lupus. Immunol Res (1998) 0.80
Adjunctive anakinra in patients with active rheumatoid arthritis despite methotrexate, or leflunomide, or cyclosporin-A monotherapy: a 48-week, comparative, prospective study. Rheumatology (Oxford) (2008) 0.80
Absence of radiographic progression of hip arthritis during infliximab treatment for ankylosing spondylitis. Clin Rheumatol (2013) 0.80
CD40L overexpression on T cells and monocytes from patients with systemic lupus erythematosus is resistant to calcineurin inhibition. Lupus (2002) 0.79
Expression of CD28, CTLA4, CD80, and CD86 molecules in patients with autoimmune rheumatic diseases: implications for immunotherapy. Clin Immunol Immunopathol (1997) 0.79
Increased expression of CD154 (CD40L) on stimulated T-cells from patients with psoriatic arthritis. Rheumatology (Oxford) (2006) 0.78
Are clusters of patients with distinct clinical expression present in Behçet's disease? Clin Exp Rheumatol (2009) 0.78
Increased levels of intercellular adhesion molecule 1 in patients with systemic lupus erythematosus: comment on the article by Mason et al. Arthritis Rheum (1994) 0.78
13q deletion in chronic lymphocytic leukemia: characterization of E4.5, a novel chromosome condensation regulator-like guanine nucleotide exchange factor. Leuk Lymphoma (2003) 0.78
Gene therapy in systemic lupus erythematosus. Curr Gene Ther (2005) 0.77
Thoracoabdominal motion in ankylosing spondylitis: association with standardised clinical measures and response to therapy. Ann Rheum Dis (2008) 0.77
Absence of p53 gene mutations in skin fibroblasts derived from patients with systemic sclerosis. Eur J Clin Invest (2002) 0.77
Molecular and immunohistochemical study of class I growth factor receptors in squamous cell lung carcinomas. Pathol Res Pract (1995) 0.77
Characterization of in vivo mutated T cell clones from patients with systemic lupus erythematosus. Clin Immunol Immunopathol (1995) 0.77
The effect of diabetes mellitus on the prevalence of rheumatoid arthritis: a case-control study. Diabet Med (2008) 0.77
Clinical and laboratory parameters in adult diabetics with and without calcific shoulder periarthritis. Calcif Tissue Int (1991) 0.76
Cardiopulmonary hemodynamics in systemic sclerosis and response to nifedipine and captopril. Am J Med (1991) 0.76
Circulating levels of TNF-like cytokine 1A correlate with the progression of atheromatous lesions in patients with rheumatoid arthritis. Clin Immunol (2013) 0.76
Education and imaging. Gastrointestinal: intestinal vasculitis associated with systemic lupus erythematosus. J Gastroenterol Hepatol (2008) 0.76
Glucocorticoid effects on myocardial performance in patients with systemic sclerosis. Clin Exp Rheumatol (2001) 0.75
Infliximab treatment-induced formation of autoantibodies is common in Behçet's disease. Clin Exp Rheumatol (2007) 0.75
Gout and neurological abnormalities associated with cardiomyopathy in a young man. Ann Rheum Dis (1990) 0.75
Twenty-four hours urinary hydroxyproline excretion in long-term experimental diabetes mellitus. Horm Metab Res (1993) 0.75
Allelic imbalance at the 5q14 locus is associated with decreased apoptotic rate in non-small cell lung carcinomas (NSCLCs). Possible synergistic effect with p53 gene alterations on apoptosis. Lung Cancer (2000) 0.75
Macrovascular disease of coronaries and cerebral arteries in streptozotocin-induced diabetic rats. A controlled, comparative study. Exp Clin Endocrinol Diabetes (1998) 0.75
Why is p53-inducible gene 3 rarely affected in cancer? Oncogene (2010) 0.75
Adamantiadis-Behçet's disease in sisters. Clin Rheumatol (1996) 0.75
Tuberculosis after anti-TNF therapy: a continuous learning process. Scand J Rheumatol (2012) 0.75
Personal characteristics may affect evaluation of teaching: a prospective study in medical students. Med Teach (2013) 0.75
Abnormal spatial QRS-T angle, a marker of ventricular repolarisation, predicts serious ventricular arrhythmia in systemic sclerosis. Clin Exp Rheumatol (2012) 0.75